Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with FAB/LMB-based chemotherapy regimen with rituximab

Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris, France; Université Paris Cité, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, Paris
Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif
Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif
Department of Pediatric Oncology and Haematology, University Hospital of Lille, Lille
Department of Pediatric Oncology and Haematology, University Hospital of Rennes, Rennes
Department of Pediatric Oncology and Haematology, University Hospital of Rouen, Rouen
Pediatric hematology and oncology department, University Hospital of Nantes, Nantes
Department of Biopathology, Morphology Unit, Gustave Roussy, Université Paris Saclay, Villejuif
Department of Pediatric Oncology and Haematology, University Hospital of Bordeaux, Bordeaux
Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon
Department of Pediatric Oncology and Haematology, University Hospital of Montpellier, Montpellier
Department of nuclear medicine, University Hospital Tenon, Paris
Department of Pediatric Oncology and Haematology, University Hospital of Tours, Tours
SIREDO Oncology Center, Institut Curie, PSL Research University, Paris
Department of biopathology, University Hospital Necker Enfants Malades, Université Paris Cité, Paris
Department of nuclear medicine, University Hospital Tenon, Paris
Department of Pediatric Oncology and Haematology, University Hospital of Toulouse, Toulouse
Pediatric Oncology and Hematology Department, University Hospital of Nancy (CHRU Nancy), Nancy
Department of Pediatric Oncology and Haematology, University Hospital of Nice, Nice
Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris
Pediatric Hematology Oncology Department, University Hospital of Strasbourg, Strasbourg
Department of Pediatric Hematology Immunology and Oncology, La Timone Hospital, APHM, Marseille
Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris
Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris
Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif
Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM Unité 1015
Haematologica Early view Jul 11, 2024 https://doi.org/10.3324/haematol.2024.285403

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.285403
 
Published
2024-07-11
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
54
PDF Downloads
27

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online